J S Smolen Selected Research

J S Smolen Research Topics

Disease

55	Rheumatoid Arthritis 09/2020 - 01/2000
13	Necrosis 09/2020 - 07/2000
13	Systemic Lupus Erythematosus (Libman-Sacks Disease) 04/2012 - 08/2000
6	Disease Progression 05/2014 - 06/2000
6	Arthritis (Polyarthritis) 07/2013 - 01/2001
5	Osteoarthritis 03/2020 - 01/2000
5	Rheumatic Diseases (Rheumatism) 01/2017 - 11/2004
5	Inflammation (Inflammations) 07/2013 - 05/2001
3	Psoriatic Arthritis 03/2016 - 01/2012
3	Joint Diseases (Joint Disease) 06/2007 - 11/2000
3	Pain (Aches) 05/2004 - 02/2000
2	Infections 06/2018 - 10/2006
2	Injection Site Reaction 07/2009 - 10/2006
2	Nausea 10/2006 - 09/2001
2	Proteinuria 07/2005 - 01/2001
2	Glomerulonephritis 01/2005 - 05/2004
2	Acute-Phase Reaction 01/2004 - 12/2002
2	Mixed Connective Tissue Disease (MCTD) 07/2002 - 08/2000
2	Alopecia (Baldness) 09/2001 - 06/2000
2	Autoimmune Diseases (Autoimmune Disease) 04/2001 - 10/2000
1	Candidiasis (Moniliasis) 06/2018
1	Communicable Diseases (Infectious Diseases) 06/2018
1	Latent Tuberculosis 06/2018
1	Ankylosing Spondylitis 01/2014
1	Axial Spondyloarthritis 01/2014
1	Connective Tissue Diseases (Connective Tissue Disease) 01/2014
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2014
1	Experimental Arthritis 01/2012
1	Tuberculosis (Tuberculoses) 06/2010
1	Bacterial Infections (Bacterial Infection) 06/2010
1	Pharyngitis (Sore Throat) 07/2009
1	Laryngitis 07/2009
1	Amyloidosis 11/2008
1	Asthenia 10/2006
1	Headache (Headaches) 10/2006

Drug/Important Bio-Agent (IBA)

19	Antirheumatic Agents (DMARD)IBA 05/2015 - 06/2000
10	Methotrexate (Mexate)FDA LinkGeneric 06/2009 - 06/2000
9	CytokinesIBA 01/2010 - 10/2000
9	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2009 - 11/2000
8	AutoantibodiesIBA 07/2013 - 01/2000
7	Sulfasalazine (Azulfidine)FDA LinkGeneric 07/2009 - 06/2000
6	Infliximab (Remicade)FDA Link 05/2014 - 11/2000
6	Leflunomide (Arava)FDA LinkGeneric 10/2003 - 06/2000
4	Interleukin-1 (Interleukin 1)IBA 06/2018 - 02/2001
3	Etanercept (Enbrel)FDA Link 03/2020 - 10/2006
3	InterleukinsIBA 06/2018 - 10/2000
3	GlucocorticoidsIBA 06/2010 - 07/2005
2	Immunoglobulins (Immunoglobulin)IBA 06/2018 - 07/2005
2	Tumor Necrosis Factor InhibitorsIBA 02/2017 - 03/2016
2	Interleukin-6 (Interleukin 6)IBA 01/2017 - 05/2001
2	Antinuclear AntibodiesIBA 01/2014 - 01/2001
2	Immunoglobulin G (IgG)IBA 07/2013 - 07/2005
2	Abatacept (Orencia)FDA Link 03/2013 - 04/2009
2	Monoclonal AntibodiesIBA 06/2010 - 11/2000
2	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 11/2005 - 11/2004
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2005 - 05/2004
2	Heterogeneous-Nuclear Ribonucleoproteins (Informatin)IBA 07/2002 - 08/2000
2	Proteins (Proteins, Gene)FDA Link 07/2002 - 12/2000
2	AntibodiesIBA 07/2002 - 11/2000
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2002 - 01/2001
2	EnzymesIBA 08/2001 - 06/2000
2	Interleukin-2 (IL2)IBA 08/2001 - 04/2001
1	Biosimilar PharmaceuticalsIBA 09/2020
1	Interleukin-12 (IL 12)IBA 06/2018
1	mepolizumabIBA 06/2018
1	eculizumab FDA Link 06/2018
1	tocilizumab (atlizumab)FDA Link 06/2018
1	siltuximabIBA 06/2018
1	rilonacept FDA Link 06/2018
1	canakinumab FDA Link 06/2018
1	ixekizumabIBA 06/2018
1	secukinumabIBA 06/2018
1	brodalumabIBA 06/2018
1	Ustekinumab (CNTO 1275)FDA Link 06/2018
1	Antiviral Agents (Antivirals)IBA 06/2018
1	Complement System Proteins (Complement)IBA 06/2018
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 06/2018
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 06/2018
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 06/2018
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2017
1	Certolizumab Pegol FDA Link 05/2015
1	pristane (pristan)IBA 07/2013
1	Immunoglobulin M (IgM)IBA 07/2013
1	Immunosuppressive Agents (Immunosuppressants)IBA 04/2012
1	Heme Oxygenase-1IBA 01/2012
1	Heme (Haem)IBA 01/2012
1	Carbon MonoxideIBA 01/2012
1	IronIBA 01/2012
1	Biliverdine (Biliverdin)IBA 01/2012
1	InterferonsIBA 01/2009
1	Histones (Histone)IBA 01/2009
1	ametantrone (HAQ)IBA 02/2008
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2008
1	Anabolic AgentsIBA 06/2007
1	Rituximab (Mabthera)FDA Link 02/2007

Therapy/Procedure

24	Therapeutics 03/2020 - 07/2000
2	Drug Therapy (Chemotherapy) 01/2002 - 01/2001
1	Biological Therapy 06/2018
1	Chemoprevention 06/2018
1	Renal Dialysis (Hemodialysis) 11/2008